Qi Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Outcomes of RALOX-HAIC-based Combination Therapy for Unresectable Hepatocellular Carcinoma with Radiomics-Powered Prediction.
Journal: Academic radiology
Published: September 21, 2025
Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP.
Journal: International journal of surgery (London, England)
Published: March 03, 2025
Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 22, 2024
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: July 04, 2023
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
Journal: Frontiers in immunology
Published: February 03, 2022
ViRBase v3.0: a virus and host ncRNA-associated interaction repository with increased coverage and annotation.
Journal: Nucleic acids research
Published: September 13, 2021
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Journal: Frontiers in immunology
Published: October 04, 2020
Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
Journal: Journal of biomedical nanotechnology
Published: May 23, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026